Korean Journal of Clinical Pharmacy (한국임상약학회지)

Korean College Of Clinical Pharmacy (한국임상약학회)
권호 표지

Pharmacokinetics of Cefetamet Pivoxil in Korean Healthy Subject

건강한 한국 성인에서 세페타메트 피복실의 약물동태

  • 노금한 (대구가톨릭대학교 약학대학) ;
  • 강원구 (대구가톨릭대학교 약학대학)
  • Received : 2010.03.22
  • Accepted : 2010.04.27
  • Published : 2010.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Cefetamet pivoxil is a prodrug of cefetamet possessing a broad spectrum of activity against many aerobic gram-positive and -negative organisms. Although many literatures in abroad had introduced its pharmacokinetics about two decays ago, no data have been revealed in Korean subjects. Therefore, this study was aimed to investigate the pharmacokinetics of cefetamet following a single oral administration of cefetamet pivoxil in Korean healthy volunteers. After an overnight fast, a tablet of cefetamet pivoxil (500 mg) was given to eight volunteers, and blood samples were serially taken up to 12 h. Plasma concentrations of cefetamet were determined by HPLC with UV detection. Cefetamet reached the peak concentration ($2.0{\pm}1.3\;{\mu}g/ml$) at $3.0{\pm}0.8$ h, and mono-exponentially decayed at a half-life of $2.6{\pm}0.9$ h. Three volunteers represented very low systemic exposure compared to the others, which provided very large inter-individual variation in Cmax, and AUC. The present results were discussed and reviewed with the previously published data, and a couple of points are suggested for clinical trials of this drug in Korean subject including bioequivalence study.

Keywords

References

  1. Wise R, Andrews JM, Piddock LJV. In vitro activity of Ro 15-8074 and Ro 19-5247, two orally administered cephalosporine metabolites. Antimicrob Agents Chemother. 1986; 29: 1067-1072. https://doi.org/10.1128/AAC.29.6.1067
  2. Koup JR, Dubach UC, Brandt R., et al., Pharmacokinetics of cefetamet (Ro 15-8074) and cefetamet pivoxil (Ro 15- 8075) after intravenous and oral doses in humans. Antimicrob Agents Chemother. 1988; 32: 573-579. https://doi.org/10.1128/AAC.32.4.573
  3. Blouin BA, Kneer J, Ambros RJ, et al., Influence of antacid and ranitidine on the pharmacokinetics of oral cefetamet pivoxil. Antimicrob Agents Chemother. 1990; 34: 1744-1748. https://doi.org/10.1128/AAC.34.9.1744
  4. Jelinska A, Dobrowolski L, Oszczapowicz I. The influence of pH, temperature and buffers on the degradation kinetics of cefetamet pivoxil hydrochloride in aqueous solutions. J Pharm Biomed Anal. 2004; 35: 1273-1277. https://doi.org/10.1016/j.jpba.2004.03.017
  5. Wyss R, Bucheli F. Determination of cefetamet and its orally active ester, cefetamet pivoxyl, in biological fluids by high-performance liquid chromatography. J Chromatogr 1988; 430: 81-92. https://doi.org/10.1016/S0378-4347(00)83136-9
  6. Hayton WL, Walstad RA, Thuemann-Nielsen E, et al., Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in children. Antimicrob Agents Chemother. 1991; 35: 720-725. https://doi.org/10.1128/AAC.35.4.720
  7. Tam YK, Kneer J, Dubach UC, et al., Pharmacokinetics of cefetamet pivoxil (Ro 15-8075) with ascending oral doses in normal healthy volunteers. Antimicrob Agents Chemother. 1989; 33: 957-959. https://doi.org/10.1128/AAC.33.6.957
  8. Tam YK, Kneer J, Dubach UC, et al., Effects of timing of food and fluid volume on cefetamet pivoxil absorption in healthy normal volunteers. Antimicrob Agents Chemother. 1990; 34: 1556-1559. https://doi.org/10.1128/AAC.34.8.1556
  9. Hayton WL, Kneer J, Blouin RA, et al., Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with hepatic cirrhosis. Antimicrob Agents Chemother. 1990; 34: 1318-1322. https://doi.org/10.1128/AAC.34.7.1318
  10. Kneer J, Tam YK, Blouin RA, et al., Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with renal insufficiency. Antimicrob Agents Chemother. 1989; 33: 1952-1957. https://doi.org/10.1128/AAC.33.11.1952
  11. Zimmerli W, Sansano S, Wittke B. Pharmacokinetics of cefetamet in plasma ans skin blister fluid. Antimicrob Agents Chemother. 1996; 40: 102-104.